Résultats de la recherche - 6 results
Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification.
laboratories. In most cases, the misidentifications obtained were associated with closely related species. The variability observed for a few isolates could be due to variations in the protein extraction ...
Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe.
billion people are infected with, leading to 10 million new cases of active tuberculosis and 1.5 million deaths annually. Universal access to drug susceptibility testing (DST) has become a World Health ...
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.
multidrug-resistant tuberculosis. In this molecular epidemiological study, we prospectively defined outbreak cases with 24-locus mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU- VNTR) ...
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
TB cohort, suggesting that carbapenems may be beneficial for the treatment of difficult-to-treat TB cases. Health Topics: Tuberculosis Tuberculose Tuberculose Service: Maladies bactériennes ...
Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs
(480 000 new cases), impeding the treatment of infected patients. Current TB drug resistance research is mainly focused on the genomic level, using WGS to search for resistance-causing mutations. ...
Global transcriptional analyses of Mycobacterium tuberculosis using old and new drugs
(TB) alongside HIV as a leading cause of death by infectious diseases. In combination, the spread of (multi-)drug resistant Mycobacterium tuberculosis is rising (480 000 new cases), impeding the ...